How were Cochlear's earnings last quarter?

Cochlear Limited (ASX:COH) posted its quarterly earnings results on Tuesday, February, 19th. The company reported $2.15 EPS for the quarter, missing the consensus estimate of $2.19 by $0.04. Cochlear had a trailing twelve-month return on equity of 20.04% and a net margin of 16.30%.

How often does Cochlear pay dividends? What is the dividend yield for Cochlear?

Cochlear announced a Interim dividend on Monday, March 18th. Stockholders of record on Sunday, April 14th will be paid a dividend of 2.00 per share on Sunday, April 14th. This represents a dividend yield of 0.6%. The ex-dividend date of this dividend is Wednesday, March 20th. This is a positive change from the stock's previous Interim dividend of A$1.55. Read our dividend analysis for COH .

Is Cochlear a good dividend stock?

Cochlear (ASX:COH) pays an annual dividend of A$4.00 per share and currently has a dividend yield of 1.19%. The dividend payout ratio is 75.05%. Payout ratios above 75% are not desirable because they may not be sustainable. Read our dividend analysis for COH .

What other stocks do shareholders of Cochlear own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cochlear investors own include iShares Core S&P 500 ETF (IVV) , CSL (CSL) , ResMed (RMD) , Rio Tinto Group (RIO) , Altium (ALU) , Abbott Laboratories (ABT) , Afterpay (APT) , Appen (APX) , Cross Timbers Royalty Trust (CRT) and Janus Henderson Group (HGG) .

ASX:COH

Cochlear (COH) Stock Price, News & Analysis

→ This company has increased its dividend every year for 54 years (From DTI) (Ad)

Free COH Stock Alerts

Compare

Today's Range: N/A
50-Day Range: N/A
52-Week Range: N/A

Volume: 201,277 shs
Average Volume: N/A
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: 1.19%
Price Target: N/A

Stock Analysis

Get Cochlear alerts:

Ad TradingTips

3 Sub-$10 Stocks to Buy for 2024

Often, investors will overlook stocks just because they're cheap. It's a common thought that a cheap price tag means that something must be wrong with the company. But this couldn't be further from the case in many instances.

Get your FREE look at these THREE companies right here.

About Cochlear Stock (ASX:COH)

Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.

Ad TradingTips

3 Sub-$10 Stocks to Buy for 2024

Get your FREE look at these THREE companies right here.

COH Stock News Headlines

April 19, 2024 | finance.yahoo.com

Cochlear receives FDA clearance to lower the age for the Osia System to 5-years-old

April 2, 2024 | fxstreet.com

Cochlear Limited Elliott Wave technical forecast [Video]

April 19, 2024 | Paradigm Press (Ad)

Biden replacement revealed?

A former CIA insider just announced a disturbing prediction… Biden will withdraw as the Democrat nominee on June 13.

March 25, 2024 | finance.yahoo.com

Investing in Cochlear (ASX:COH) five years ago would have delivered you a 104% gain

March 21, 2024 | markets.businessinsider.com

Cochlear Limited (CHEOF) Gets a Sell from Morgan Stanley

March 8, 2024 | finance.yahoo.com

Should You Be Adding Cochlear (ASX:COH) To Your Watchlist Today?

February 19, 2024 | markets.businessinsider.com

Here’s Why Cochlear (COH) Shares Fell Despite Robust Profits

February 19, 2024 | msn.com

ASX Large Caps: Property stocks smashed after Lendlease-led rout, a2 Milk soars on solid guidance

April 19, 2024 | Paradigm Press (Ad)

Biden replacement revealed?

A former CIA insider just announced a disturbing prediction… Biden will withdraw as the Democrat nominee on June 13.

February 18, 2024 | msn.com

ASX 200 opens 0.1% higher; Westpac, Cochlear, Ampol report earnings

February 11, 2024 | markets.businessinsider.com

Analysts Conflicted on These Healthcare Names: Cochlear Limited (OtherCHEOF) and Demant (OtherWILLF)

February 8, 2024 | markets.businessinsider.com

Here’s Why Cochlear (COH) Shares Rose Today

February 7, 2024 | msn.com

ASX Health Stocks: Cochlear upgrades guidance, Chimeric up 12pc after commencing Phase 1B trial on leukaemia

February 7, 2024 | msn.com

Closing Bell: Interest rates the only thing steady about local markets on Tuesday

February 5, 2024 | fool.com.au

Why is the Cochlear share price tumbling 5% on Tuesday?

January 24, 2024 | finance.yahoo.com

Cochlear and TechSee Win Silver in the 13th Annual Best in Biz Awards 2023

January 21, 2024 | sg.finance.yahoo.com

Cochlear Ltd (OC5.SG)

December 17, 2023 | finance.yahoo.com

Unpleasant Surprises Could Be In Store For Cochlear Limited's (ASX:COH) Shares

December 13, 2023 | morningstar.com

Curro Holdings Ltd COH

November 25, 2023 | finance.yahoo.com

Is Cochlear Limited's (ASX:COH) Recent Stock Performance Tethered To Its Strong Fundamentals?

November 15, 2023 | fool.com.au

Analysts say these world-class ASX 200 blue chip shares are buys

November 15, 2023 | morningstar.com

Cochlear Ltd COH

November 10, 2023 | finanznachrichten.de

Envoy Medical, Inc: Envoy Medical Announces Publication of Additional Patent for Implantable Cochlear Systems

October 31, 2023 | fool.com.au

Buy and hold this ASX 200 share which is a long term market leader: broker

October 24, 2023 | forbes.com

Cochlear Implants vs. Hearing Aids: What’s The Difference?

October 20, 2023 | finance.yahoo.com

Cochlear Limited's (ASX:COH) institutional investors lost 4.5% last week but have benefitted from longer-term gains

October 4, 2023 | finance.yahoo.com

Investors in Cochlear (ASX:COH) have seen notable returns of 41% over the past five years

See More Headlines

Receive COH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cochlear and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 2/19/2019
Ex-Dividend for 4/14 Dividend: 3/20/2024
Dividend Payable: 4/14/2024
Today: 4/19/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: ASX
Sector: Medical
Industry: Medical Devices
Sub-Industry: N/A
Current Symbol: ASX:COH
CUSIP: N/A
CIK: N/A
Web: www.cochlear.com
Phone: +61-2-94286555
Fax: N/A
Employees: 4,800
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): A$5.33
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: 3.87
Net Income: $350.40 million
Net Margins: 16.30%
Pretax Margin: N/A
Return on Equity: 20.04%
Return on Assets: 11.80%

Debt

Debt-to-Equity Ratio: 11.60
Current Ratio: 2.57
Quick Ratio: 1.93

Sales & Book Value

Annual Sales: $2.15 billion
Price / Sales: 0.00
Cash Flow: N/A
Price / Cash Flow: 123.45
Book Value: A$27.17 per share
Price / Book: N/A

Miscellaneous

Outstanding Shares: 65,490,000
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: 0.46

10 "Recession Proof" Stocks That Will Thrive in Any Market

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Key Executives

Mr. Diggory William Howitt BE (Hons) (Age 57)
MBA, CEO, MD, President & Executive Director
Comp: $4.78M
Mr. Stuart Sayers
Chief Financial Officer
Mr. Jan Janssen MSc Elec Eng (Age 59)
Chief Technology Officer
Comp: $2.04M
Ms. Karen O'Driscoll
Chief Information Officer
Ms. Kristina Devon
Vice President of Investor Relations
Rob McGrory
Group General Counsel
Ms. Jennifer Stevenson
VP of Corporate Communications & Brand
Mr. Dean Phizacklea
Senior Vice President of Global Strategic Marketing
Ms. Jennifer Hornery
Senior Vice President of Global People & Culture
Mr. Greg Bodkin BE (Hons)
MComm (UNSW), Senior Vice President of Global Supply Chain

Key Competitors

View All Competitors

Insiders

COH Stock Analysis - Frequently Asked Questions

How were Cochlear's earnings last quarter?: Cochlear Limited (ASX:COH) posted its quarterly earnings results on Tuesday, February, 19th. The company reported $2.15 EPS for the quarter, missing the consensus estimate of $2.19 by $0.04. Cochlear had a trailing twelve-month return on equity of 20.04% and a net margin of 16.30%.
How often does Cochlear pay dividends? What is the dividend yield for Cochlear?: Cochlear announced a Interim dividend on Monday, March 18th. Stockholders of record on Sunday, April 14th will be paid a dividend of 2.00 per share on Sunday, April 14th. This represents a dividend yield of 0.6%. The ex-dividend date of this dividend is Wednesday, March 20th. This is a positive change from the stock's previous Interim dividend of A$1.55.
Read our dividend analysis for COH.
Is Cochlear a good dividend stock?: Cochlear (ASX:COH) pays an annual dividend of A$4.00 per share and currently has a dividend yield of 1.19%. The dividend payout ratio is 75.05%. Payout ratios above 75% are not desirable because they may not be sustainable.
Read our dividend analysis for COH.
What other stocks do shareholders of Cochlear own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Cochlear investors own include iShares Core S&P 500 ETF (IVV), CSL (CSL), ResMed (RMD), Rio Tinto Group (RIO), Altium (ALU), Abbott Laboratories (ABT), Afterpay (APT), Appen (APX), Cross Timbers Royalty Trust (CRT) and Janus Henderson Group (HGG).

This page (ASX:COH) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial